Not Medicare Enrolled

Dr. Justin Spooner, MD

Psychiatry · Ponte Vedra Beach, FL
Low-engagement
230 CANAL BLVD STE 2, Ponte Vedra Beach, FL 32082
9042806701
In practice since 2007 (18 years)
NPI: 1720269459 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Spooner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Spooner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Spooner

Dr. Justin Spooner is a psychiatry specialist in Ponte Vedra Beach, FL, with 18 years of NPI registration.

Between the years covered by Open Payments, Dr. Spooner received a total of $11,283 from 70 pharmaceutical and/or device companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Spooner is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice $11,283 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 115625 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$11,283
Total received (2018-2024)
Avg $1,612/year across 7 years
Top 8% in FL for psychiatry
70
Companies
497
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,925 (79.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,359 (20.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$682
2023
$454
2022
$1,569
2021
$4,906
2020
$1,919
2019
$1,063
2018
$690

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$2,421
Teva Pharmaceuticals USA, Inc.
$864
Boston Scientific Corporation
$659
Amgen Inc.
$582
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$521
Stimwave Technologies Incorporated
$518
Otsuka America Pharmaceutical, Inc.
$438
AbbVie Inc.
$363
Biohaven Pharmaceuticals, Inc.
$275
Biohaven Pharmaceutical Holding Company Ltd.
$266
Novartis Pharmaceuticals Corporation
$242
Lilly USA, LLC
$235
ABBVIE INC.
$231
Corium, LLC
$226
Takeda Pharmaceuticals U.S.A., Inc.
$219
Allergan, Inc.
$198
Medtronic USA, Inc.
$197
UPSHER-SMITH LABORATORIES LLC
$183
Almatica Pharma LLC
$155
Radius Health, Inc.
$143
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$133
Lundbeck LLC
$133
Flowonix Medical Incorporated
$132
Zyla Life Sciences
$121
Neos Therapeutics, LP
$115
Avanir Pharmaceuticals, Inc.
$113
ITI, Inc.
$109
Tris Pharma Inc
$105
BOSTON SCIENTIFIC CORPORATION
$103
RedHill Biopharma Inc.
$90
Supernus Pharmaceuticals, Inc.
$88
Neurocrine Biosciences, Inc.
$79
Vanda Pharmaceuticals Inc.
$68
ARBOR PHARMACEUTICALS, INC.
$65
Daiichi Sankyo Inc.
$61
Merck Sharp & Dohme Corporation
$51
Axsome Therapeutics, Inc.
$50
Collegium Pharmaceutical, Inc.
$43
IDORSIA PHARMACEUTICALS US INC
$42
IBSA Pharma Inc.
$40
EISAI INC.
$38
Nevro Corp.
$38
PFIZER INC.
$35
Virtus Pharmaceuticals LLC
$33
Noven Therapeutics, LLC
$33
Pacira Therapeutics, Inc.
$30
Ironshore Pharmaceuticals Inc.
$28
TerSera Therapeutics LLC
$28
Purdue Pharma L.P.
$24
Arbor Pharmaceuticals, Inc.
$23
Nalu Medical, Inc.
$23
Janssen Pharmaceuticals, Inc
$22
SCILEX PHARMACEUTICALS INC.
$21
Pear Therapeutics (US), Inc.
$21
BioDelivery Sciences International, Inc.
$18
Vertos Medical, Inc.
$17
Egalet US Inc
$15
Kaleo, Inc.
$14
Zyla Life Sciences, Inc.
$14
Merck Sharp & Dohme LLC
$14
Aytu BioPharma, Inc.
$13
Horizon Therapeutics plc
$13
Pernix Therapeutics Holdings, Inc.
$13
Orexo US, Inc.
$12
Sentynl Therapeutics, Inc.
$12
Captiva Spine Inc
$12
Bioventus LLC
$11
DePuy Synthes Sales Inc.
$11
Curonix LLC
$11
Forte Bio-Pharma LLC
$10
Top 3 companies account for 35.0% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADAPTIVESTIM · AIMOVIG · AJOVY · AUSTEDO · Adzenys XR-ODT · Aimovig · Amitiza · Auvelity · Azstarys · BELBUCA · BELSOMRA · BRINTELLIX · CAPLYTA · CONFIDENCE · COTEMPLA XR-ODT · Dayvigo · Durolane · Dyanavel XR · EMGALITY · EVZIO · GENERAL PAIN MANAGEMENT · GRALISE · HETLIOZ · Horizant · INGREZZA · JANUVIA · JORNAY PM · LEVORPHANOL TARTRATE · LOREEV XR · Levorphanol · Licart · Morphabond ER · Movantik · NAPRELAN · NUEDEXTA · NURTEC ODT · Nalocet · Nalu Neurostimulation System · PENNSAID · PRIALT · Prometra II · QULIPTA · QUVIVIQ · RELISTOR · RELISTOR ORAL · RESTORE · REXULTI · REYVOW · SPECTRA WAVEWRITER · SPRAVATO · SPRIX · SUPERION · SYMPROIC · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion · Superion Indirect Decompression System · TOSYMRA · TRINTELLIX · TROKENDI XR · Tirosint · Transfasten · Tymlos · UBRELVY · VRAYLAR · VYEPTI · VYVANSE · WAVEWRITER ALPHA · XTAMPZA · Xelstrym · ZOHYDRO ER · ZORVOLEX · ZTLido · Zilretta · Zubsolv · mild Device Kit · reSET-O
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (79%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for psychiatry in FL.

Looking for a psychiatry specialist in Ponte Vedra Beach?
Compare psychiatrists in the Ponte Vedra Beach area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
129
Per 100K population
44.1
County median income
$106,169
Nearest hospital
BAPTIST MEDICAL CENTER BEACHES
11.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Spooner is a psychiatry specialist, with low-engagement industry engagement in the top 8% of FL peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Spooner receive payments from pharmaceutical companies?
Yes. Dr. Spooner received a total of $11,283 from 70 companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Spooner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →